Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Brief report: the association of neurofibromatosis type 1 and autism.

Authors: R Eldridge; M B Denckla; E Bien; S Myers; M I Kaiser-Kupfer; A Pikus; S L Schlesinger; D M Parry; J M Dambrosia; M A Zasloff
Journal: Am J Dis Child Date: 1989-07

6. Learning problems in neurofibromatosis patients.

Authors: S B Stine; W V Adams
Journal: Clin Orthop Relat Res Date: 1989-08 Impact factor: 4.176

7. Subgroups in autism: are there behavioural phenotypes typical of underlying medical conditions?

Authors: C Gillberg
Journal: J Intellect Disabil Res Date: 1992-06

Review 8. Autism: familial aggregation and genetic implications.

Authors: S E Folstein; M L Rutter
Journal: J Autism Dev Disord Date: 1988-03

9. Neurofibromatosis and psychological processes.

Authors: C K Varnhagen; S Lewin; J P Das; P Bowen; K Ma; M Klimek
Journal: J Dev Behav Pediatr Date: 1988-10 Impact factor: 2.225

10. Neurofibromatosis in infantile autism and other types of childhood psychoses.

Authors: S E Mouridsen; L B Andersen; S A Sörensen; B Rich; T Isager
Journal: Acta Paedopsychiatr Date: 1992

19 in total

1. Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice.

Authors: D Ehninger; Y Sano; P J de Vries; K Dies; D Franz; D H Geschwind; M Kaur; Y-S Lee; W Li; J K Lowe; J A Nakagawa; M Sahin; K Smith; V Whittemore; A J Silva
Journal: Mol Psychiatry Date: 2010-11-16 Impact factor: 15.992

Review 2. Immune dysfunction in autism: a pathway to treatment.

Authors: Milo Careaga; Judy Van de Water; Paul Ashwood
Journal: Neurotherapeutics Date: 2010-07 Impact factor: 7.620

Review 3. Next-Generation Sequencing in Autism Spectrum Disorder.

Authors: Stephan J Sanders
Journal: Cold Spring Harb Perspect Med Date: 2019-08-01 Impact factor: 6.915

Review 4. Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders.

Authors: Dan Ehninger; Alcino J Silva
Journal: Trends Mol Med Date: 2010-11-04 Impact factor: 11.951

Review 5. Autism: in search of susceptibility genes.

Authors: Janine A Lamb; Jeremy R Parr; Anthony J Bailey; Anthony P Monaco
Journal: Neuromolecular Med Date: 2002 Impact factor: 3.843

6. Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network.

Authors: Deborah A Bilder; Amanda V Bakian; David A Stevenson; Paul S Carbone; Christopher Cunniff; Alyson B Goodman; William M McMahon; Nicole P Fisher; David Viskochil
Journal: J Autism Dev Disord Date: 2016-10

7. Autism traits in the RASopathies.

Authors: Brigid Adviento; Iris L Corbin; Felicia Widjaja; Guillaume Desachy; Nicole Enrique; Tena Rosser; Susan Risi; Elysa J Marco; Robert L Hendren; Carrie E Bearden; Katherine A Rauen; Lauren A Weiss
Journal: J Med Genet Date: 2013-10-07 Impact factor: 6.318

8. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly.

Authors: Joseph D Buxbaum; Guiqing Cai; Pauline Chaste; Gudrun Nygren; Juliet Goldsmith; Jennifer Reichert; Henrik Anckarsäter; Maria Rastam; Christopher J Smith; Jeremy M Silverman; Eric Hollander; Marion Leboyer; Christopher Gillberg; Alain Verloes; Catalina Betancur
Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2007-06-05 Impact factor: 3.568

Review 9. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders.

Authors: Pat Levitt; Daniel B Campbell
Journal: J Clin Invest Date: 2009-04-01 Impact factor: 14.808

Review 10. Pax6 3' deletion results in aniridia, autism and mental retardation.

Authors: L K Davis; K J Meyer; D S Rudd; A L Librant; E A Epping; V C Sheffield; T H Wassink
Journal: Hum Genet Date: 2008-03-06 Impact factor: 4.132